FlowSense

About Rhaeos

Rhaeos is a venture-backed, private medical device company founded in 2018 and based in Evanston, Illinois. The company's core innovation is the FlowSense platform, a patent-protected, wearable sensor that non-invasively measures fluid flow, starting with the critical unmet need of detecting shunt malfunction in hydrocephalus patients. With FDA Breakthrough Device designation and significant non-dilutive grant funding, Rhaeos is advancing its clinical program. The company aims to reduce the substantial clinical and economic burden of shunt failure, which affects over 1 million Americans and costs the US healthcare system over $2 billion annually.

Therapeutic Areas